NCT01583049View on ClinicalTrials.gov

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

CompletedOBSERVATIONAL
Enrollment

556

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Diphtheria, Tetanus and Pertussis
Trial Locations (22)

Unknown

Centre 11, Almería

Centre 12, Almería

Centre 13, Almería

Centre 14, Almería

Centre 15, Almería

Centre 16, Almería

Centre 17, Almería

Centre 18, Almería

Centre 19, Almería

Centre 20, Almería

Centre 21, Almería

Centre 22, Almería

Centre 10, Madrid

Centre 1, Madrid

Centre 2, Madrid

Centre 3, Madrid

Centre 4, Madrid

Centre 5, Madrid

Centre 6, Madrid

Centre 7, Madrid

Centre 8, Madrid

Centre 9, Madrid

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01583049 - Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children | Biotech Hunter | Biotech Hunter